Treatment of Patients with Cirrhosis and Ascites
Treatment of Patients with Cirrhosis and Ascites
复制标题
肝硬化腹水患者的治疗
DOI：
10.1055/s-2007-1007202
复制
发表时间：
1997
影响因子：
4.2
通讯作者：
B. Runyon
中科院分区：
文献类型：
--
作者：
B. Runyon
近年来，由于关于旧治疗的新信息以及新治疗，肝硬化和液体超负荷患者的治疗经历了实质性变化。治疗的目标是最大限度地提高预期寿命和生活质量。一般来说，腹水的发展是肝硬化自然史中的一个里程碑，表明预期寿命较短。适合肝移植的患者应在出现腹水后接受该手术的评估。等待移植的患者以及不适合此程序的患者应通过限制饮食钠和利尿剂处方进行管理。这种方法在> 90%的患者中有效控制液体过载。只有10%的这种简单的药物治疗失败的人应该考虑进行二线治疗。
The treatment of patients with cirrhosis and fluid overload has undergone substantial change in recent years, because of new information regarding old treatments, as well as new treatments. The goals of treatment are to maximize life expectancy and quality of life. Development of ascites is a landmark in the natural history of cirrhosis signaling poor life expectancy, in general. Patients who are appropriate candidates for liver transplantation should undergo evaluation for this procedure after development of ascites. Patients awaiting transplantation as well as non-candidates for this procedure should be managed by restriction of dietary sodium and prescription of diuretics. This approach is effective in controlling fluid overload in > 90% of patients. Only the 10% who fail this simple medical treatment should be considered for second-line therapy.
速尿对慢性肝病腹水肾血流动力学的直接影响。
影响因子：
29.4
作者：
Daskalopoulos,G;Laffi,G;Morgan,T;Pinzani,M;Harley,H;Reynolds,T;Zipser,RD
通讯作者：
Zipser,RD
影响因子：
158.5
作者：
RICH, MW;BECKHAM, V;CARNEY, RM
通讯作者：
CARNEY, RM